Funding Details
- Date Award
- May 13, 2024
- Vertical
- Healthcare
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2019
- Traction
- Gatehouse Bio has made significant progress in leveraging single-cell genomics and machine learning for autoimmune disease therapeutics. The company is advancing its proprietary platform to identify and target key immune cell populations, with the aim of delivering personalized treatments for improved patient outcomes.
- Organizations Involved
- SOSV
- Company Description
- Gatehouse Bio (formerly known as SRnalytics) is a biotechnology company specializing in developing novel therapeutics for autoimmune diseases. The company's proprietary platform leverages single-cell genomics and machine learning to identify and target key immune cell populations involved in autoimmune responses. Gatehouse Bio's approach aims to deliver personalized treatments that modulate the immune system with high precision, potentially offering more effective and safer alternatives to traditional autoimmune therapies.
- Market
- Biotechnology
- Location
-
San Francisco,
CA,
US
- Coinvestors
- SOSV
Links